Microbot Medical receives FDA 510(k) clearance for Liberty endovascular robotic system
[REGULATORY ACTION]Sep 8, 2025 · Microbot Medical · LIBERTY Endovascular Robotic System · North Carolina, USA
Failure Mode
REGULATORY ACTION
Event Date
Sep 8, 2025
Primary Entity
Microbot Medical
Robotic Platform
LIBERTY Endovascular Robotic System
Jurisdiction / Location
North Carolina, USA
Audit Standard
Physical State Verified
Incident Abstract & Audit Findings
Microbot Medical received FDA 510(k) clearance for its LIBERTY Endovascular Robotic System, the first single-use remotely operated endovascular surgical robot. The company announced key 2026 milestones for commercialization.
System & Fleet Architecture
Operating Manufacturer
Hardware Platform
Operational Sectors
Primary Sources & Evidentiary Filings
- Inspect Filing
https://ir.microbotmedical.com/news-releases/news-release-details/microbot-medicalr-receives-fda-510k-clearance-its-libertyr
https://ir.microbotmedical.com/news-releases/news-release-details/microbot-medicalr-receives-fda-510k-clearance-its-libertyr
Related Incidents & Failure Precedents
6 records on file- NHTSA opens probe into 1.2 million Tesla Model 3 and Model Y vehicles over front suspension failures[REGULATORY ACTION]
Jul 31, 2026 · Tesla · Tesla Robotaxi (Model Y ADS) · Orlando, Florida, USA
Details - NHTSA grants Zoox temporary exemption to commercially deploy up to 2,500 robotaxis annually[REGULATORY ACTION]
Jul 30, 2026 · Zoox · Zoox Robotaxi · Miami
Details - Zoox clears final federal hurdle, receives NHTSA exemption to launch paid robotaxi service[REGULATORY ACTION]
Jul 30, 2026 · Zoox · Zoox Robotaxi · Miami
Details - NHTSA grants Zoox first-ever commercial FMVSS exemption for purpose-built robotaxi[REGULATORY ACTION]
Jul 30, 2026 · Zoox · Zoox Robotaxi · Miami
Details - NHTSA launches $5M SAE ITC partnership to develop first-ever AV performance standards and updates AV technical guidance[REGULATORY ACTION]
Jul 30, 2026 · Zoox · Zoox Robotaxi · Miami
Details - NHTSA grants Zoox temporary commercial deployment exemption for up to 2,500 robotaxis annually for two years[REGULATORY ACTION]
Jul 30, 2026 · Zoox · Zoox Robotaxi · Miami
Details
Incident Context & FAQ
What happened in Microbot Medical receives FDA 510(k) clearance for Liberty endovascular robotic system?
Microbot Medical received FDA 510(k) clearance for its LIBERTY Endovascular Robotic System, the first single-use remotely operated endovascular surgical robot. The company announced key 2026 milestones for commercialization.
When did this incident occur?
The incident is recorded as occurring on September 8, 2025 on the DEPLOY registry. The date reflects the underlying real-world event, not the registry record's creation date.
What robot was involved in Microbot Medical receives FDA 510(k) clearance for Liberty endovascular robotic system?
LIBERTY Endovascular Robotic System by Microbot Medical is the recorded robot involved in this incident at North Carolina, USA.
Has anyone responded to Microbot Medical receives FDA 510(k) clearance for Liberty endovascular robotic system?
No responses to this incident are recorded on the DEPLOY registry. Operators, manufacturers, or affected parties can submit responses to the editorial team; absence is not a guarantee no response was issued.
What is the current status of Microbot Medical receives FDA 510(k) clearance for Liberty endovascular robotic system?
This incident is an active record on the DEPLOY registry; no retraction or correction has been issued.